Conditions: Asthma
Keywords: Asthma Pediatric asthma
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 95
Healthy volunteers: no

Brief summary:
This study is designed to evaluate the repeat-dose safety and effectiveness of a bronchodilator inhaler relative to placebo (inactive drug inhaler) in children aged 4-11 years with asthma. The dosing period lasts three weeks and starts following a three-week run-in period.

Detailed description:

Arms:
arm 1: ProAir(TM) HFA, Breath Actuated Inhalation Aerosol arm 2: Placebo

Interventions: intervention 1: Albuterol intervention 2: Placebo
Intervention descriptions: intervention 1: Albuterol 90mcg intervention 2: Placebo

Protocol document: